Xenon Pharmaceuticals XENE Unveils Robust Azetukalner Phase III Data Q3 NDA Filing Plans at Bloom Burton Conference Is Brookfield BBU stock breaking key levels Q4 2025 Earnings Underperform Is eHealth EHTH stock overvalued by the market eHealth reports 36 EPS miss vs Street estimates